Back to results
CompletedPhase 1Phase 2

Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

NCT01596751

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California, San Francisco

San Francisco, California, United States

+2 additional locations

View on ClinicalTrials.gov
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer — TrialFind